Blodplatehemming og mageproblemer [1]

Tidsskrift for den Norske Laegeforening

Volumn 127, Issue 1, 2007, Pages 64-

  Arnesen, Øyvind ^a   Riis, Jon Sigurd ^b  

^a BRISTOL MYERS SQUIBB   (United States)

^b Sanofi aventis

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; ANTIULCER AGENT; CLOPIDOGREL; DRUG DERIVATIVE; OMEPRAZOLE; TICLOPIDINE;

CHEMICALLY INDUCED DISORDER; DRUG COMBINATION; GASTROINTESTINAL HEMORRHAGE; HUMAN; NOTE;

ANTI-ULCER AGENTS; ASPIRIN; DRUG THERAPY, COMBINATION; GASTROINTESTINAL HEMORRHAGE; HUMANS; OMEPRAZOLE; PLATELET AGGREGATION INHIBITORS; TICLOPIDINE;

EID: 33846907834     PISSN: 00292001     EISSN: 08077096     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Johansen M. Platehemmerbehandling ved tidligere gastrointestinal blødning forårsaket av acetylsalisylsyre. Tidsskr Nor Lægeforen 2006; 126: 2802-4.
2. Chan FKL, Ching JYL, Hung LCT et al. Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding. N Engl J Med 2005; 352: 238-44.
3. Doggrell SA. Aspirin and esomeprazole are superior to clopidogrel in preventing recurrent ulcer bleeding. Expert Opin Pharmacother 2005; 6: 1253-6.
4. Folketrygdloven §5-14. Vedlegg 1/Klopidogrel.
5. Folketrygdloven §5-14. Vedlegg 1/Esomeprazol.